Citius Pharmaceuticals Inc

XNAS:CTXR 3:03:21 PM EDT

0.57

+0.01 (+1.39%)

Market Cap (Intraday)	15.59M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$2.95 Million
Adjusted EPS	-$0.41

See more estimates

10-Day MA	$0.58
50-Day MA	$0.59
200-Day MA	$0.74

See more pivots

Citius Pharmaceuticals Inc Stock, XNAS:CTXR

11 Commerce Drive, 1st floor, Cranford, New Jersey 07016

United States of America

Phone: +1.908.967.6677

Number of Employees: 23

http://www.citiuspharma.com

Description

Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite. The company was founded by Ralph Montrone on January 23, 2007 and is headquartered in Cranford, NJ.